Toku Eyes

Developer of AI-powered retinal image analysis for early disease detection. This company offers tools that analyze retinal images to identify indicators of various health conditions, including cardiovascular risk and chr

placeAuckland, Auckland, New Zealand calendar_todayFounded 2018 groups14 employees language tokueyes.com

Registered entities

Innovation

4 patent families (3 granted) — focus: Physics & computing, Human necessities; filing pace accelerating. Cited 61 times.

YearFilings
20221
20232
20241
20253
20261

Social engagement

Social engagement: 2.6K social following, 5 posts in the last 12 months — below the industry typical range.

Investor mix

18 investors on record; lead investors include Icehouse Ventures, National Vision, Topconhealthcare; 1 has since exited.

Investor typeCountShare
Venture capital211%
Private equity16%
Other / undisclosed1583%

Recent activity

17 Oct 2025
Partnership
Toku
16 Sep 2025
Event
Vision Expo West live demo of BioAge using OptosAdvance
16 Sep 2025
Event
Vision Expo West live demo of BioAge using Topcon Harmony
Coming soon